NCT00002141View on ClinicalTrials.gov

A Phase I Trial to Evaluate the Safety and Pharmacokinetics of 1592U89

PHASE1CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

July 31, 1994

Conditions

HIV Infections

Interventions

DRUG

Abacavir sulfate

Trial Locations (2)

20007

Georgetown Univ Med Ctr, Washington D.C.

67214

Ctr for Phase I Research, Wichita

All Listed Sponsors

lead

Burroughs Wellcome

INDUSTRY